Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
AssigneeNovartis AG
InventorsGary Mark Coppola, Yuki Iwaki, Rajeshri Ganesh Karki, Toshio Kawanami, Gary Michael Ksander, Muneto Mogi, Robert Sun
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovartis AG
InventorsGary Mark Coppola, Yuki Iwaki, Rajeshri Ganesh Karki, Toshio Kawanami, Gary Michael Ksander, Muneto Mogi, Robert Sun
Estimating the term…
The present invention provides a compound of formula I′; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, X and n are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
A compound of the formula (I′):
8-9. (canceled)
A method of treating a disorder or a disease associated with neutral endopeptidase EC. 3.4. 24.11. activity in a subject in need thereof, comprising:
17-19. (canceled)
Dependencies are inferred from the claim text.